StonvexLoading…
StonvexStonvexStonvexCore line items from LWAY's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $63.01M | $212.50M | $157.13M | $99.99M |
Operating Income | $6.33M | $16.17M | $12.41M | $7.37M |
Net Income | $4.67M | $13.86M | $11.32M | $4.25M |
EPS (Diluted) | $0.30 | $0.89 | $0.74 | $0.51 |
Total Assets | $120.50M | $105.61M | $109.53M | $98.27M |
Total Liabilities | $30.18M | $19.79M | $26.76M | $19.57M |
Cash & Equivalents | $5.60M | $5.57M | $22.99M | $21.22M |
Free Cash Flow OCF − CapEx | $-6.66M | $-16.41M | $1.01M | $-764.00K |
Shares Outstanding | 15.28M | 15.23M | 15.23M | 15.22M |